Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.
Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this update appears to be metadata only with no substantive changes to the study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded the Locations section and California as a study location. Updated the page to revision v3.3.3 and removed the earlier California Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%
- Check39 days agoChange DetectedDeleted the last known status entry for Megan Daly, MD, University of California, Davis, including the date (2023-04) and verification note.SummaryDifference0.4%
- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no visible edits to study details, contacts, locations, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check61 days agoChange DetectedResults Submitted is now shown, indicating that study results have been submitted. Outdated notices about funding status and 'No Results Posted' have been removed.SummaryDifference0.4%
- Check75 days agoChange DetectedNo significant changes detected in the Study Details page; the content remains the same.SummaryDifference0.4%
Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.